London (AFP) – A new study, published in the journal BMJ, was the first to compare thrombocytopenia rates between adenovirus and mRNA vaccines — such as Pfizer — across multiple countries. It has found that AstraZeneca’s Covid vaccine is linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab. Several countries …